The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly
Introduction:Acromegaly is a rare disease caused by overproduction of growth hormone (GH) secreted from a benign pituitary adenoma. It has been shown in many studies that the incidence of cancer is increased in patients with acromegaly with increased GH and insulin-like growth factor-1 (IGF-1). Espe...
| Published in: | İstanbul Medical Journal |
|---|---|
| Main Authors: | Mustafa Demirpençe, Hamiyet Yılmaz, Ayfer Çolak, Merve Zeytinli, Demet İnce, Barış Önder Pamuk |
| Format: | Article |
| Language: | English |
| Published: |
İstanbul Training and Research Hospital
2020-01-01
|
| Subjects: | |
| Online Access: |
http://imj.galenos.com.tr/archives/archive-detail/article-preview/the-evaluation-of-thrombospondin-1-levels-in-patie/34656
|
Similar Items
Research progress on the role of thrombospondin 2 in malignant tumors
by: MA Jiajunyan, RUI Tiannan, ZHANG Yongsheng
Published: (2023-12-01)
by: MA Jiajunyan, RUI Tiannan, ZHANG Yongsheng
Published: (2023-12-01)
Acromegaly and Colorectal Neoplasm: An Update
by: Leandro Kasuki, et al.
Published: (2022-06-01)
by: Leandro Kasuki, et al.
Published: (2022-06-01)
Relationship of thrombospondin-1 and thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients
by: Dogan Serdar, et al.
Published: (2023-06-01)
by: Dogan Serdar, et al.
Published: (2023-06-01)
Screening colonoscopy tests in acromegaly patients – authors’ observations
by: Joanna Elżbieta Malicka, et al.
Published: (2016-09-01)
by: Joanna Elżbieta Malicka, et al.
Published: (2016-09-01)
Prevalence of colonic polyps among patients with Acromegaly
by: S. Pathmanathan, et al.
Published: (2018-08-01)
by: S. Pathmanathan, et al.
Published: (2018-08-01)
Thrombospondin expression in myofibers stabilizes muscle membranes
by: Davy Vanhoutte, et al.
Published: (2016-09-01)
by: Davy Vanhoutte, et al.
Published: (2016-09-01)
Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer
by: Jing Li, et al.
Published: (2024-12-01)
by: Jing Li, et al.
Published: (2024-12-01)
Relationship between elevated circulating thrombospondin‐1 levels and vascular complications in diabetes mellitus
by: Na Guo, et al.
Published: (2024-02-01)
by: Na Guo, et al.
Published: (2024-02-01)
Causal Relationship Between Acromegaly and Colon Cancer: A Two-sample Mendelian Randomization Study
by: WEI Wei, et al.
Published: (2023-12-01)
by: WEI Wei, et al.
Published: (2023-12-01)
Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study
by: Christian Rosendal, et al.
Published: (2024-04-01)
by: Christian Rosendal, et al.
Published: (2024-04-01)
IMMUNOREGULATORY PROPERTIES OF THROMBOSPONDIN-1, A EXTRACELLULAR MATRIX COMPONENT AND ANGIOGENESIS INHIBITOR
by: S. A. Kuznetsova, et al.
Published: (2014-07-01)
by: S. A. Kuznetsova, et al.
Published: (2014-07-01)
Duhok acromegaly; a prospective cohort study
by: Bayar Ahmed Qasim
Published: (2023-03-01)
by: Bayar Ahmed Qasim
Published: (2023-03-01)
Thrombospondin 4, a mediator and candidate indicator of pain
by: Yanqiong Wu, et al.
Published: (2024-06-01)
by: Yanqiong Wu, et al.
Published: (2024-06-01)
Thrombospondin-1 induction and VEGF reduction by proteasome inhibition
by: Fawzia Bardag-Gorce, et al.
Published: (2023-02-01)
by: Fawzia Bardag-Gorce, et al.
Published: (2023-02-01)
Risk of intracranial meningioma in patients with acromegaly: a systematic review
by: Amy X. Guo, et al.
Published: (2024-06-01)
by: Amy X. Guo, et al.
Published: (2024-06-01)
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action
by: Marco Rusnati, et al.
Published: (2010-04-01)
by: Marco Rusnati, et al.
Published: (2010-04-01)
Ectopic Acromegaly Secondary to Bronchial Tumor; a Case Report of Rare Occurrence.
by: Sara Sohail, et al.
Published: (2021-01-01)
by: Sara Sohail, et al.
Published: (2021-01-01)
Thrombospondin‐1 Regulates Trophoblast Necroptosis via NEDD4‐Mediated Ubiquitination of TAK1 in Preeclampsia
by: Haoyue Hu, et al.
Published: (2024-06-01)
by: Haoyue Hu, et al.
Published: (2024-06-01)
Increased excitatory connectivity and epileptiform activity in thrombospondin1/2 knockout mice following cortical trauma
by: Haifeng Shu, et al.
Published: (2024-10-01)
by: Haifeng Shu, et al.
Published: (2024-10-01)
Secondary erythrocytosis in patient with acromegaly
Published: (2011-12-01)
Published: (2011-12-01)
Is circulating survivin altered in acromegaly?
by: Esra Ademoglu, et al.
Published: (2018-06-01)
by: Esra Ademoglu, et al.
Published: (2018-06-01)
Hypertensive Patients Exhibit Enhanced Thrombospondin-1 Levels at High-Altitude
by: Kavita Sharma, et al.
Published: (2021-08-01)
by: Kavita Sharma, et al.
Published: (2021-08-01)
Improvement of acromegaly control with multimodal therapy in Romania
by: Mihai C. Marinescu, et al.
Published: (2020-06-01)
by: Mihai C. Marinescu, et al.
Published: (2020-06-01)
Pasireotide: A new option for treatment of acromegaly
by: Filiz Eksi Haydardedeoglu, et al.
Published: (2020-06-01)
by: Filiz Eksi Haydardedeoglu, et al.
Published: (2020-06-01)
Evaluation of thrombospondin 1 as a novel biomarker in pediatric-onset systemic lupus erythematosus
by: Chenxi Liu, et al.
Published: (2025-03-01)
by: Chenxi Liu, et al.
Published: (2025-03-01)
Differential Diagnosis of Acromegaly: Pachydermoperiostosis Two New Cases from Turkey
by: Emine Kartal Baykan, et al.
Published: (2022-09-01)
by: Emine Kartal Baykan, et al.
Published: (2022-09-01)
The Association of Fetal and Maternal Thrombospondin-1 (TSP-1) and Vascular Endothelial Growth Factor (VEGF) Serum Levels with Selected Fetal and Maternal Characteristics
by: Obeidat RA, et al.
Published: (2025-10-01)
by: Obeidat RA, et al.
Published: (2025-10-01)
Successful Pregnancy in a Patient with Long-Standing Acromegaly – a Case Report
by: Gliga Maximilian Cosma, et al.
Published: (2020-09-01)
by: Gliga Maximilian Cosma, et al.
Published: (2020-09-01)
A single-center prospective study evaluating the relationship of tumor consistency on remission in acromegaly patients
by: Eren Yilmaz, et al.
Published: (2025-01-01)
by: Eren Yilmaz, et al.
Published: (2025-01-01)
Identification of scavenger receptors and thrombospondin‐type‐1 repeat proteins potentially relevant for plastid recognition in Sacoglossa
by: Jenny Melo Clavijo, et al.
Published: (2020-11-01)
by: Jenny Melo Clavijo, et al.
Published: (2020-11-01)
The mechanobiology of extracellular matrix: a focus on thrombospondins
by: Ying Zhao, et al.
Published: (2025-07-01)
by: Ying Zhao, et al.
Published: (2025-07-01)
Adenoma size and postoperative IGF-1 levels predict surgical outcomes in acromegaly patients: results of the Swiss Pituitary Registry (SwissPit)
by: Julia Kempf, et al.
Published: (2018-08-01)
by: Julia Kempf, et al.
Published: (2018-08-01)
Thrombospondin 1 Mediates Autophagy Upon Inhibition of the Rho-Associated Protein Kinase Inhibitor
by: Kirk Patrick Carreon Catral, et al.
Published: (2024-11-01)
by: Kirk Patrick Carreon Catral, et al.
Published: (2024-11-01)
The anticancer potential of thrombospondin-1 by inhibiting angiogenesis and stroma reaction during cervical carcinogenesis
by: Ming-Ping Wu, et al.
Published: (2016-05-01)
by: Ming-Ping Wu, et al.
Published: (2016-05-01)
Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria
by: Maria Kamusheva, et al.
Published: (2023-01-01)
by: Maria Kamusheva, et al.
Published: (2023-01-01)
Epiphora and proptosis as a presenting complaint in acromegaly: Report of two cases with review of literature
by: Mansi Mehra, et al.
Published: (2013-01-01)
by: Mansi Mehra, et al.
Published: (2013-01-01)
An Overview of the Musculoskeletal Comorbidity of Acromegaly: A Case with Non-traumatic Spontaneous Rectus Femoris Rupture
by: Nurdan Yılmaz, et al.
Published: (2021-04-01)
by: Nurdan Yılmaz, et al.
Published: (2021-04-01)
Skeletal complications in acromegaly
by: Arnika Wydra, et al.
Published: (2023-08-01)
by: Arnika Wydra, et al.
Published: (2023-08-01)
Prevalence of acromegaly and clinical guidelines
by: V. S. Pronin, et al.
Published: (2014-12-01)
by: V. S. Pronin, et al.
Published: (2014-12-01)
Plasma Thrombospondin-1 in Etiology-Specific Associations with Proteinuria Events in Pediatric Chronic Kidney Disease
by: Pei-Chen Lu, et al.
Published: (2025-08-01)
by: Pei-Chen Lu, et al.
Published: (2025-08-01)
Similar Items
-
Research progress on the role of thrombospondin 2 in malignant tumors
by: MA Jiajunyan, RUI Tiannan, ZHANG Yongsheng
Published: (2023-12-01) -
Acromegaly and Colorectal Neoplasm: An Update
by: Leandro Kasuki, et al.
Published: (2022-06-01) -
Relationship of thrombospondin-1 and thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients
by: Dogan Serdar, et al.
Published: (2023-06-01) -
Screening colonoscopy tests in acromegaly patients – authors’ observations
by: Joanna Elżbieta Malicka, et al.
Published: (2016-09-01) -
Prevalence of colonic polyps among patients with Acromegaly
by: S. Pathmanathan, et al.
Published: (2018-08-01)
